Introduction {#sec1}
============

The global pandemic of Coronavirus Disease 2019 (COVID-19) has led to unprecedented cancellation of elective surgeries in the United States and has posed a significant strain on the finances of health care systems. A recent report by the CovidSurg Collaborative projects that 28.4 million elective surgeries worldwide will be canceled or postponed in 2020.[@bib1] During the height of the pandemic, tier classifications of surgical procedures were created to stratify the urgency of operations. The goals of these classification systems were to maintain optimal patient outcomes, to preserve essential equipment and resources needed to handle the volume of critically ill patients, and to uphold the crucial public health guidelines for physical distancing.[@bib2], [@bib3], [@bib4], [@bib5], [@bib6] Early reports have described the impact of these restrictions on local practice patterns amid the pandemic.[@bib7] ^,^ [@bib8] The objective of this study is to describe the vascular surgery practice pattern changes in the inpatient, ambulatory, and vascular laboratory settings associated with the COVID-19 pandemic in the United States during the period of April 14-24, 2020.

Methods {#sec2}
=======

***Survey Design.*** The Pandemic Practice, Anxiety, Coping, and Support Survey was an anonymous cross-sectional survey on the effects of the COVID-19 pandemic on vascular surgeons developed by the Society for Vascular Surgery (SVS) Wellness Task Force. This analysis focuses on the survey responses related to pattern changes in vascular surgery practices in the United States including the inpatient setting, ambulatory, and vascular laboratory setting. Additionally, questions regarding occupational exposure to COVID-19, adequacy of personal protective equipment (PPE), elective surgery practices, changes in call schedules, and redeployment to non-vascular surgery duties were included. The survey questions are included in the supplement. The study was reviewed by the University of Washington (UW) Human Subjects Division and deemed exempt (\#009926) due to the minimal risk and non-identifiable nature of the study. Consent by each participant was given by their individual response to the survey. A multimodality approach, previously described[@bib9], was utilized to disseminate the survey between 4/14/2020 and 4/24/2020, inclusive. Dissemination modalities included the SVS membership electronic mailing lists, other organizational mailing lists, podcasts, newsletters, and social media platforms (Supplement [Table 1](#tbl1){ref-type="table"} ). The survey data were collected using a secure REDCap (Research Electronic Data Capture) data capture platform hosted at the University of Washington.[@bib9] ^,^ [@bib10] The data were analyzed using descriptive statistics. Categorical data are presented as numbers and percentages. Continuous data are presented as means and standard deviation of the mean or median and ranges or interquartile range (IQR) where appropriate. Data were compared using the Student's t-test for normally distributed data and Wilcoxon rank-sum test for non-normally distributed data. Categorical data were compared using the Pearson Chi-square test. Data were analyzed using SPSS 19.0 for Windows (SPSS, Inc., Chicago, IL).Table 1Description of the 535 vascular surgeons who responded to the survey and their practices.N (%)N=535RegionNortheast138 (25.8)Southeast122 (22.8)Midwest126 (23.6)West/Southwest149 (27.9)GenderMale391 (73.1)Female134 (25.6)Prefer not to say7 (1.3)RaceWhite378 (70.7)Asian80 (15)Black or African American10 (1.9)American Indian or Alaska NativeNative Hawaiian or Pacific Islander3 (.6)Mixed race14 (2.6)Other21 (3.9)Prefer not to say26 (4.9)Years in practiceIn practice less than 10 years223 (41.7)In practice between 10 and 20 years156 (29.2)In practice greater than 20 years156 (29.2)Type of hospitalUrban Teaching332 (62.1)Urban Non-teaching105 (19.6)Rural Teaching31 (5.8)Rural Non-teaching25 (4.7) No response42 (7.9)Type of PracticeAcademic253 (47.3)Community172 (32.1)Multi-specialty clinic50 (9.3)Outpatient Practice only11 (2.1)Solo22 (4.1)Veterans\' Affairs or government run27 (5)Hospital size\< 50 beds4 (.7)50-99 beds4 (.7)100-200 beds49 (9.2)201-300 beds91 (17)301-400 beds83 (15.5)\>400 beds252 (47.1)Don\'t know or no response46 (8.6)I do not work at a hospital6 (1.1)Practice at more than one hospital307 (57.4)Leadership position^a^320 (59.8)[^1]

Results {#sec3}
=======

A total of 535 vascular surgeons in the United States responded to the survey from 45 states ([Figure 1](#fig1){ref-type="fig"} ) with an evenly distributed response by region (25.8% Northeast, 22.8% Southeast, 23.6% Midwest, and 27.9% West/Southwest). The estimated response rate is detailed in Supplement [Table 1](#tbl1){ref-type="table"}. New York was the state with the highest number of responses (N=50, 9.3%), followed by California (N=45, 8.4%), and Michigan (N=38, 7.1%). A large proportion of the respondents were male (73.1%), White (70.7%), practiced in urban settings (81.7%), and teaching hospitals (66.8%). Almost half of all respondents worked in a facility with over 400 beds (46.4%, [Table 1](#tbl1){ref-type="table"}). Most of the respondents completed the entire survey (91.2%), and there was no significant regional difference in completion rates (87.7%, 95.1%, 89.7%, and 92.6% respectively, P=.16).Figure 1The geographic distribution of 535 vascular surgeons who responded to the survey. The regions were classified as Northeast (Connecticut, Delaware, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont), Midwest (Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, Ohio, South Dakota, and Wisconsin), Southeast (Alabama, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Virginia, and West Virginia) and West/Southwest (Arizona, California, Colorado, Hawaii, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, and Washington).

COVID-19 related changes to in-hospital surgical practice {#sec3.1}
---------------------------------------------------------

Of the 480 vascular surgeons who answered the questions regarding intensive care unit (ICU) capacity, most noted that ICU beds were available at their hospital (N=402, 83.7%), while others had patients boarding in the emergency department (14.6%), postoperative care unit, and/or operating rooms (11%). The lack of ICU beds was most common in the Northeast region, where over a quarter noted that ICU beds were at capacity, and patients were being boarded in the PACU/operating room ([Table 2](#tbl2){ref-type="table"} ).Table 2COVID-19 occupational exposure and related changes to in-hospital surgical practiceN(%)AllRegionPNortheastSoutheastMidwestWest/SouthwestIntensive Care Unit (ICU) availability (N=480)ICU beds available402 (83.8)72 (62.1)105 (90.5)95 (83.3)130 (97)\<.001ICUs are full, patients are boarding in the ED25 (5.2)11 (9.5)5 (4.3)7 (6.1)2 (1.5)0.038ICUs are full, patients are boarding in the PACU/OR53 (11)31 (26.7)6 (5.2)13 (11.4)3 (2.2)\<.001The primary hospital or facility where you work has (N=492)Pre-operative testing of patients for COVID 19243 (49.4)67 (55.4)55 (46.6)52 (45.2)69 (50)0.404COVID-19 OR protocols451 (91.7)109 (90.1)109 (92.4)109 (94.8)124 (89.9)0.47Adheres to ACS/SVS guidelines for allowable surgeries during COVID 19425 (86.4)105 (86.8)100 (84.7)102 (88.7)118 (85.5)0.826Adequate personal protective equipment (PPE)396 (80.5)98 (81)87 (73.7)101 (87.8)110 (79.7)0.059Elective Surgeries Cancelled (N=493)452 (91.7)114 (94.2)113 (95.8)105 (91.3)120 (86.3)0.032COVID-19 exposure (N=535)Operated on a patient with COVID-1995 (17.8)31 (22.5)29 (23.8)21 (16.7)14 (9.4)0.006Operated/performed a procedure on patient with COVID-19131 (24.5)47 (34.1)39 (32)26 (20.6)19 (12.8)\<.001Operated/performed a procedure on patient who was later diagnosed with a COVID-19 infection96 (17.9)36 (26.1)30 (24.6)17 (13.5)13 (8.7)\<.001Personally considered at \"high\" risk for COVID-19 infection147 (27.6)47 (34.4)33 (27.3)29 (23.2)38 (25.5)0.201Assist in duties other than those of a vascular surgeon (N=492)171 (34.8)67 (55.4)35 (29.7)37 (32.5)32 (23)\<.001Call schedule (N=472 )Any call schedule changes in the last two weeks216 (45.8)63 (54.8)45 (38.8)64 (58.7)44 (33.3)\<.001Less Call27 (5.7)12 (10.4)1 (.9)8 (7.3)6 (4.5)0.014More Call57 (12.1)20 (17.4)13 (11.2)10 (9.2)14 (10.6)0.233Same call but changed distribution of call133 (28.2)31 (27)31 (26.7)47 (43.1)24 (18.2)\<.001

The vast majority of respondents noted that all elective surgical procedures were canceled (452/493, 91.2%) with no significant differences by type of hospital (92.6% teaching hospitals vs 89.2% non-teaching hospitals, P=.238). A small number of vascular surgeons 8.3% (41/493) indicated that they were still performing elective cases focused primarily on dialysis access (58.5%), followed by aortic repair (51.2%), and lower extremity revascularization (48.8%, [Figure 2](#fig2){ref-type="fig"} ). Elective surgery cancellations were most prevalent in the Northeast (94.2%) and least frequent in the West/Southwest region (86.3%).Figure 2The regional distribution of continued elective vascular surgical cases as reported by 41 respondents

Most respondents reported institutional adherence to the SVS and/or the American College of Surgeons (ACS) guidelines for elective surgery during COVID-19 (86%, 425/492). Call schedules were modified for 45.9%, with the majority noting that they had the same overall number of call days in an altered distribution. Just over one-third of study participants (171, 34.8%) were asked to assist in duties other than those of a vascular surgeon, most frequently in the Northeast region. The primary redeployment was to the ICU, and the most common re-appropriation duty was placement of central venous catheters ([Figure 3](#fig3){ref-type="fig"} ).Figure 3The regional distribution of duties to which vascular surgeons were redeployed. These included Managing patients in the intensive care unit \[ICU\], taking shifts to assist the ICU teams in placing lines \[Lines\], seeing patients in the Emergency Department \[ED\], Covering other surgery services \[Other surgery\], Administrative tasks \[Administrative\], and additional educational/research responsibilities \[Education/Research\]

COVID-19 Operating Experience and Exposure {#sec3.2}
------------------------------------------

A total of 452/492 (91.7%) respondents indicated they had dedicated COVID-19 operating room protocols at their hospital, and 49% had pre-operative testing of patients for COVID-19 available. Just under one-fourth of vascular surgeons (N=131; 24.5%) had either operated on a patient or placed a central line (including hemodialysis catheters) on a patient with a confirmed COVID-19 infection ([Table 2](#tbl2){ref-type="table"}).

Ninety-five vascular surgeons (17.8%) noted operating on a patient with a confirmed COVID-19 infection. In the majority of cases, the surgeons waited outside the operating room during the intubation (53.6%), and most used N-95 masks during the operation. When asked about their interaction within the operating rooms during the pandemic, some specific comments included "*I chose to wear excessive PPE on all patients during this time*", "*I have not operated since early March without an N95*", and "*I have elected to do nearly all operations without intubation*". Central line placement on a patient with confirmed COVID-19 infection was performed by 96/535 (17.9%) of vascular surgeons. The majority indicated they had adequate PPE (94.8%). Ninety-six respondents (17.9%) operated on a patient who was later found to have COVID-19 infection. In these circumstances, few were subsequently self-quarantined (6%) and/or tested for COVID-19 (10.4%).

Four (0.7%) respondents reported testing positive for COVID-19. A total of 147 (47.5%) indicated they were considered at \"high\" risk of being infected with COVID-19. Most were male (83%), and in practice greater than 20 years (54.4%). A third of these (34%) noted that they had operated on or placed a central line in a patient with confirmed COVID-19, with 14.3% of respondents being from New York State. Only two tested positive for COVID-19.

The Northeast had the most respondents who reported operating on a patient with COVID-19 or who was later found to be COVID-19 positive, while the West/Southwest region had the least (22.5% vs. 9.4%; P=.006).

COVID-19 related changes in outpatient services {#sec3.3}
-----------------------------------------------

The majority of vascular surgeons reported disruption to their outpatient clinic/ambulatory center schedules (440/493, 89.2%). Changes included limited clinic/ambulatory center hours (350/493, 71%) and use of telehealth (400/493, 81.1%, [Table 3](#tbl3){ref-type="table"} ). A total of 15 respondents (2.8%) noted that due to the crisis they offered no clinic and no telehealth services.Table 3COVID-19 related changes in outpatient and diagnostic vascular lab servicesN (%)AllRegionPNortheastSoutheastMidwestWest/SouthwestAmbulatory clinic schedulesNumber of respondents492121118114139Patient visits via telehealth400 (81.3)103 (85.1)88 (74.6)93 (81.6)116 (83.5)0.164Limited clinic/ambulatory centers hours350 (71.1)90 (74.4)82 (69.5)83 (72.8)95 (68.3)0.692Regular clinic/ambulatory centers hours53 (10.8)8 (6.6)18 (15.3)10 (8.8)17 (12.2)0.143No clinic and no telehealth15 (3)5 (4.1)2 (1.7)4 (3.5)4 (2.9)0.727Outpatient Based Laboratory (OBL)Number of respondents20346544657Closed104 (51.2)30 (65.2)17 (31.5)37 (80.4)20 (35.1)\<.001Offloading volume from the hospital32 (15.8)4 (8.7)15 (27.8)5 (10.9)8 (14)0.036Performing procedures as usual18 (8.9)3 (6.5)8 (14.8)07 (12.3)0.047Performing urgent procedures only82 (40.4)13 (28.3)31 (57.4)9 (19.6)29 (50.9)\<.001Cases currently treated at OBLCritical limb ischemia87 (42.9)12 (26.1)33 (61.1)9 (19.6)33 (57.9)\<.001Dialysis access maintenance81 (39.9)13 (28.3)36 (66.7)6 (13)26 (45.6)\<.001Wound care32 (15.8)7 (15.2)10 (18.5)1 (2.2)14 (24.6)0.018Venous23 (11.3)6 (13)11 (20.4)06 (10.5)0.015Vascular labNumber of respondents472120111111130Open as usual49 (10.4)8 (6.7)20 (18)4 (3.6)17 (13.1)0.002Urgent outpatient studies351 (74.4)85 (70.8)88 (79.3)86 (77.5)92 (70.8)0.303Urgent inpatient studies235 (49.5)60 (50)41 (36.9)73 (65.8)61 (46.9)\<.001Closed40 (8.5)15 (12.5)5 (4.5)7 (6.3)13 (10)0.12

Two-hundred and three respondents (47.7%) indicated that they have an office-based lab (OBL). Of those, 99 (48.8%) were still open, with the majority performing urgent procedures only and focused on peripheral arterial disease and dialysis access ([Table 3](#tbl3){ref-type="table"}). Regional variation was identified with more OBL practices closing in the Northeast (65.2%) and Midwest (80.4) as compared to the Southeast (31.5%) and West/Southwest (35.1%).

COVID-19 related changes in vascular lab scheduling {#sec3.4}
---------------------------------------------------

Most of the respondents (96.7%) have a vascular laboratory, and the majority of vascular labs were performing urgent outpatient studies (351; 74.4%, [Table 3](#tbl3){ref-type="table"}). Some vascular laboratories limited imaging to life or limb-threatening studies and others stratified imaging requests based on clinical need and urgency determined by the vascular surgeon on call. Several respondents noted the creation and establishment of a mobile vascular laboratory program that provided in-home services for select types of patients.

Discussion {#sec4}
==========

The COVID-19 pandemic has changed the landscape of surgical practice in the United States, including cancellation/postponement of elective surgical cases and rapid dissemination of surgical practice guidelines with the goal of to preserving PPE and build capacity within health care systems.[@bib1] ^,^ [@bib3] ^,^ [@bib11], [@bib12], [@bib13], [@bib14], [@bib15] This survey covers the period of April 14-24, 2020, during which cases in the United States rose from 492,416 to 895,766 cases with the Northeastern region most heavily affected.[@bib16]

The majority of survey respondents implemented specific operating room protocols and had adequate PPE at their primary institution. In areas where shortages were evident or expected, such as the Northeast region, active measures by hospital leadership were instituted to convert PACU and operating rooms to ICU beds to allow for the surge, with operating rooms and PACUs being suitable based on their location, size, and available infrastructure.[@bib17] ICUs were the most full in the Northeast, with a significant increase in patients boarded in the PACU/operating rooms as compared to the rest of the country.

With surgical guidelines for the pandemic in place and endorsed by surgical societies [@bib2] ^,^ [@bib3] elective vascular surgical cases were reduced significantly, if not halted completely. Not surprisingly, the majority of the respondents canceled elective cases, adhering to guidelines set forth by national surgical and specialty societies, such as the ACS and the SVS.[@bib3] ^,^ [@bib6] The West/Southwest region had the least amount of cancellations, which may represent the lower number of the COVID-19 cases at with a downward trend at the time of this survey since Washington state was ground zero for the pandemic in the United States. While only half of the respondents had pre-operative COVID-19 testing for their patients, an overwhelming majority identified dedicated COVID-19 operating protocols at their institutions. There was no geographic variation in pre-operative testing of patients for COVID-19, presence of OR protocols and PPE, or adherence to national guidelines. A focus on life-over-limb was clearly demonstrated, with the majority of continued "elective" cases focused on aortic repair and maintenance of dialysis function rather than peripheral arterial disease or venous procedures.

Along with other healthcare workers, vascular surgeons have been redeployed to perform critical activities during the pandemic that are not part of their routine practice, similar to what has been seen in other specialties.[@bib11], [@bib12], [@bib13], [@bib14], [@bib15] The most common redeployment was to the ICU, as well as the formation of central line teams to minimize multi-provider exposure and leverage the expertise of vascular surgeons. As expected, redeployment was most common in areas most affected by the pandemic, such as the Northeast region. On-call schedules were modified in terms of call distribution and frequency to promote physical distancing and minimize the exposure of multiple members of the team at a given time.

Contemporary vascular surgical practice has promoted outpatient management and encouraged the use of OBLs to offload the demands of larger hospital facilities. Despite their multiple benefits, changes in outpatient services were expected during this crisis, and many of the vascular practices limited their OBL hours -- reasons included helping to promote physical distancing, minimizing provider exposure, unavailability of staff (due to financial restrictions and/or furlough at large health systems), and most commonly, patients' fear of contracting COVID-19 in a health care facility. Most practices converted to offering consults via telephone or telemedicine/telehealth visits. The lack of in-person meetings has essentially become commonplace and telehealth is becoming a "must-have" for practice viability. Interestingly, 15 respondents noted that their offices closed, and they offered no telehealth capabilities; this was not regionally specific. Significant regional variation was identified with over 80% of OBLs in the Midwest closing as compared with only 31.5% and 35.1% in the Southeast and West/Southwest, respectively. Chronic limb-threatening ischemia and dialysis maintenance were the types of cases most frequently being performed in the OBL setting.

The majority of respondents noted a shift toward the vascular diagnostic lab performing only urgent outpatient referrals and inpatient consults at their institutions. Mitigation options revolved around decreasing the frequency of the vascular lab evaluations or reducing hours of service. Clearly, delaying vascular pathology surveillance made many uncomfortable and options to maintain such schedules were explored. Urgent outpatient studies were still being performed without regional variation, although the Midwest continued to do a large proportion of inpatient evaluations.

Several limitations exist due to the self-reported survey design, which can introduce social desirability bias, recall bias, and respondent selection bias. This survey a snapshot of 10 days during a very dynamic situation of early COVID-19 experience, with circumstances changing daily. Some of the states were on the steep part of the pandemic curve and getting ready to peak, whereas others did not see large influx of infected patients at the time of survey completion. In particular, a significant number of respondents to the survey were from the New York, Michigan, and California, all of whom were severely affected by the pandemic during this period. The majority of the respondents were from urban and teaching hospitals thus the responses reflect mostly this experience. The majority of the respondents were from urban and teaching hospitals thus the responses reflect mostly this experience. Also, surgeons may have appointments in more than one facility, such as joint appointments with the Veteran's Administration (VA). These surgeons may have selected their primary hospital rather than the VA; therefore, the VA may be underrepresented. Lastly, the timing of the survey development and dissemination coincided with the rapid development of practice guidelines and the common language we are now all familiar with such as the Vascular Activity Condition or VASCCON language or the tiers 1-3 by the ACS.[@bib3] ^,^ [@bib6] These were not incorporated in the survey design at that time thus limited the detail surrounding cancelled "elective" cases. This language will be included in future survey design.

The survey evaluated the impact of COVID-19 on vascular surgeons practicing in the United States at a single point in time. Our data show that vascular surgical care and surveillance has been restricted, and will likely continue to be limited as the COVID-19 pandemic continues. The long-term effects on vascular patients are unknown, and the greater need for preserving public health resources to the population remains a priority. The unknown sequelae of unanticipated delays on vascular surgical care and patient outcomes prompted the creation of the Vascular Surgery COVID-19 Collaborative (VASCC) to prospectively follow these impacts.[@bib18]

Conclusions {#sec5}
===========

The COVID-19 pandemic led to dramatic changes to the delivery of vascular surgical care in the United States during the period of April 14-24, 2020 and regional variations in practice patterns were identified. These included significant cancellations of elective surgical cases, reduction in outpatient visits, and lower utilization of the vascular lab. Vascular care was continued via telemedicine and for cases favoring life-over-limb.

Supplementary data {#appsec1}
==================

Supplement Table 1. Multimodal survey dissemination, potential audience, and estimated response rate.Society for Vascular Surgery and affiliated organizationsDate of DisseminationPotential AudienceSociety for Vascular Surgery (SVS) Email list^a^4/14/20203,528SVS Connect4/17/20201,203Vascular Specialist Magazine\
https://vascularspecialistonline.com/svs-needs-assessment-survey-evaluating-impact-of-covid-19-on-vascular-surgery/4/16/2020399Other outreach platformsVascular Surgeons COVID-19 WhatsApp4/14/2020256Vascular Low Frequency Disease Consortium mailing4/15/202030VA Vascular Surgeons4/15/202097Social media outreachVascular SVS \@VascularSVS4/16/20205,913Vascular Specialist Online \@VascularOnline4/16/2020351Audible bleeding \@Audiblebleeding4/16/2020985[^2]
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Type of Research:

The COVID-19 Pandemic Practice, Anxiety, Coping and Support Survey for Vascular Surgeons is an anonymous cross-sectional global survey sponsored by the Society for Vascular Surgery Wellness Committee disseminated in April 14-24, 2020. This analysis focuses on the impact of COVID-19 on the Vascular Surgery Practice in the United States during this period.

**Key Findings:** The survey evaluated 535 vascular surgeons in practice in the United States with an even distribution in the four geographic regions: Northeast, Southeast, Midwest and West/Southwest. The COVID-19 pandemic resulted in significant impact to the practice of vascular surgery across the United States with unprecedented surgery cancellation, changes in on-call schedules, and redeployment to non-vascular surgical duties. Regional variation was noted in ICU availability, outpatient based laboratory, and COVID-19 exposure.

**Take home Message:** The COVID-19 pandemic resulted in significant impact to the practice of vascular surgery across the United States with unprecedented surgical cases cancellation, changes in on-call schedules, and redeployment to non-vascular surgical duties. Regional variation was noted in ICU availability, outpatient based laboratory, and COVID-19 exposure

Table of Contents Summary

This anonymous cross-sectional global survey disseminated April 14-24, 2020, captures the dramatic impact of the COVID-19 pandemic on 535 vascular surgeons' practices in the United States and identifies regional variations.

[^1]: ^a^" Do you have an institutional leadership position (e.g. program director, vascular lab director, section head, division head, department chair)?"

[^2]: ^a^ On 4/14/2020 emails were sent to 3,528 recipients; 3,525 were received (3 bounced). Of those received 1,866 were opened (52.9%) and 381 accessed the survey directly from the email link. On 4/23/2020 a reminder email was sent to the same list. Of these, 1,263 were opened (35.8%) and 134 accessed the survey directly from the email. Suggesting that 515 respondents who were reached via the SVS email list. This accounts for approximately 16.5% if all emails opened.
